140 related articles for article (PubMed ID: 19184624)
41. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
[TBL] [Abstract][Full Text] [Related]
42. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of enteric microparticles by coacervation.
Thomas S; Chong YN; Chaw CS
Drug Dev Ind Pharm; 2013 Jul; 39(7):1142-51. PubMed ID: 23003201
[TBL] [Abstract][Full Text] [Related]
45. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
Sahoo J; Murthy PN; Biswal S; Manik
AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
[TBL] [Abstract][Full Text] [Related]
46. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
47. Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases.
Baek JS; Yeo EW; Lee YH; Tan NS; Loo SCJ
Drug Des Devel Ther; 2017; 11():1707-1717. PubMed ID: 28652708
[TBL] [Abstract][Full Text] [Related]
48. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
49. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
Devarajan PV; Sonavane GS
Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
[TBL] [Abstract][Full Text] [Related]
50. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
51. Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules.
Valot P; Baba M; Nedelec JM; Sintes-Zydowicz N
Int J Pharm; 2009 Mar; 369(1-2):53-63. PubMed ID: 19084583
[TBL] [Abstract][Full Text] [Related]
52. Risedronate-loaded Eudragit S100 microparticles formulated into tablets.
Velasquez AA; Mattiazzi J; Ferreira LM; Pohlmann L; Silva CB; Rolim CM; Cruz L
Pharm Dev Technol; 2014 May; 19(3):263-8. PubMed ID: 23506303
[TBL] [Abstract][Full Text] [Related]
53. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
54. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
56. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
[TBL] [Abstract][Full Text] [Related]
57. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
Rodrigues MR; Lanzarini CM; Ricci-Junior E
Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
[TBL] [Abstract][Full Text] [Related]
58. Spray-dried gastroretentive floating microparticles: preparation and in vitro evaluation.
Rao BP; Mathews R; Krishna KP; Baby B; Poornima
Pak J Pharm Sci; 2013 Jul; 26(4):707-13. PubMed ID: 23811446
[TBL] [Abstract][Full Text] [Related]
59. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
Alhnan MA; Kidia E; Basit AW
Eur J Pharm Biopharm; 2011 Oct; 79(2):432-9. PubMed ID: 21439376
[TBL] [Abstract][Full Text] [Related]
60. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
